There's been a lot of back and forth in the media about the pharmaceutical industry, including GSK, and the role of "ghostwriters" in preparing articles for peer-reviewed scientific journals. You should know where GSK stands.
While the requirements of medical journals have evolved over the years, our current policy is that a medical writer's substantive assistance in the content of an article is documented either by authorship or in the acknowledgements section of the publication.
We continually review our practices. We have our own guidelines on this topic. They reflect those established by the International Committee of Medical Journal Editors and PhRMA Principles on Conduct of Clinical Trials and Communication of Results. We continually review our guidelines to make sure they cover current issues.
We want to be transparent about whose work is represented and that the investigator is in control of the contents.
Leave a comment